...
首页> 外文期刊>Integrative cancer therapies. >Prolonged Progression-Free Survival in a Patient With Malignant Pleural Mesothelioma Following Korean Herbal Medicine Treatment Alone: A Case Report
【24h】

Prolonged Progression-Free Survival in a Patient With Malignant Pleural Mesothelioma Following Korean Herbal Medicine Treatment Alone: A Case Report

机译:单独韩国草药治疗后患有恶性胸膜间皮瘤的患者延长进展的存活率:案例报告

获取原文
           

摘要

Korean herbal medicine treatment (KHMT) involves treating with a combination of natural products, which have been used for thousands of years. Recently, it has been reported to be effective and safe in cancer patients. This case report demonstrates the efficacy of KHMT in a 49-year-old man with malignant pleural mesothelioma (MPM), a rare and highly aggressive cancer. The patient showed recurrent pleural effusion and was diagnosed with epithelioid MPM at cT3NxM0 stage III in December 2017. The multidisciplinary care team recommended multimodal treatment based on an extrapleural pneumonectomy, but he refused this because the treatment was aggressive and the effectiveness was unclear. He decided to undergo pemetrexed plus cisplatin chemotherapy if his condition worsened. He visited the Korean Medicine Cancer Center for alternative treatment options. A KHMT regimen, consisting of twice-daily Gunchil-dan and thrice-daily Bangam-tang, was initiated in December 2017. Since commencement of KHMT, computed tomography and X-ray imaging scans have shown no significant interval changes and progression. At 21 months into treatment (September 2019), no significant adverse events have occurred. Given that the median overall survival of patients with MPM is approximately 1 year, the ongoing progression-free survival of this patient for 21 months is relatively long. This case, therefore, suggests that KHMT is a potential treatment option for MPM patients.
机译:韩国草药治疗(KHMT)涉及用天然产品的组合治疗,这些产品已经使用了数千年。最近,据报道,癌症患者有效和安全。本案例报告显示了KHMT在一个49岁男性的患有恶性胸膜间皮瘤(MPM),罕见且高度侵略性的癌症的疗效。患者在2017年12月在CT3NXM0阶段III诊断出患有复发性胸腔积液,并在CT3NXM0阶段III诊断出上皮内酯MPM。多学科护理团队推荐基于肺部肺切除术的多峰治疗,但他拒绝这一点,因为治疗侵略性,有效性尚不清楚。如果他的病情恶化,他决定接受Pemetrexed Plus顺铂化疗。他参观了韩国医学癌症中心,以获得替代治疗方案。由每日两次Gunchil-Dan和Threat-Daily Bangam-Tang组成的KHMT方案于2017年12月开始。由于KHMT的开始,计算断层扫描和X射线成像扫描显示出没有明显的间隔变化和进展。在21个月入院(2019年9月),没有发生重大的不良事件。鉴于MPM患者的中位整体存活率约为1年,该患者的持续无进展生存率为21个月相对较长。因此,这种情况表明,KHMT是MPM患者的潜在治疗选择。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号